The Clorox Company
CLX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.62 | 0.14 | -7.62 | 0.27 |
| FCF Yield | 0.38% | 1.48% | 1.28% | 0.63% |
| EV / EBITDA | 95.41 | 35.57 | 62.15 | 72.71 |
| Quality | ||||
| ROIC | 2.62% | 9.26% | 5.12% | 4.63% |
| Gross Margin | 41.57% | 46.33% | 44.30% | 43.59% |
| Cash Conversion Ratio | 1.13 | 0.88 | 1.50 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.27% | -1.30% | -0.71% | 0.47% |
| Free Cash Flow Growth | -73.97% | -6.01% | 83.46% | -30.22% |
| Safety | ||||
| Net Debt / EBITDA | 15.41 | 5.51 | 8.09 | 8.90 |
| Interest Coverage | 4.73 | 16.88 | 8.81 | 9.32 |
| Efficiency | ||||
| Inventory Turnover | 1.45 | 2.04 | 1.46 | 1.61 |
| Cash Conversion Cycle | -101.23 | 10.60 | -101.58 | -49.96 |